National Institute on Drug Abuse Keep your Brain Healthy - Keep your Body Healthy
Link to Home Page Link to About NIDA Link to Whats New Link to In the News Link to Publications Link to Spanish Publications Link to Funding Information
Go
Information for - see right links Student Information Index link Parent-Teacher Information Index link Researcher Information Index link


NIDA Home > Publications > Research Monographs >    

Assessing Neurotoxicity of Drugs of Abuse



NIDA Research Monograph, Number 136 [Printed in 1993]


If you have the Acrobat reader plug-in for Netscape or Internet Explorer click on the document link and you will be able to view and/or print out the pages. If you have trouble viewing the document in your browser window, download the document (Windows users - right click on the link and Save as...) to your computer and get Adobe Acrobat Reader (free) in order to view it.


This monograph is not available by chapter. The Table of Contents (below) is shown to assist in locating information prior to downloading the monograph.

Download Monograph136.pdf - Assessing Neurotoxicity of Drugs of Abuse (1.8 MB)


Table of Contents

Preface-----v
Lynda Erinoff

Neurobehavioral Methods Used in Neurotoxicology-----1
Hugh A. Tilson

Behavioral Consequences of Partial Monoamine Depletion in the CNS After Methamphetamine-Like Drugs: The Conflict Between Pharmacology and Toxicology-----34
Lewis S. Seiden, William L. Woolverton, Stanley A. Lorens, Joseph E.G. Williams, Rebecca L. Corwin, Norio Hata, Mary Olimski

Strategies for Detecting Subclinical Monoamine Depletions in Humans-----53
Una D. McCann and George A. Ricaurte

Sensory Evoked Potentials: Measures of Neurotoxicity-----63
William K. Boyes

Silver Staining as a Tool for Neurotoxic Assessment-----101
Carlos A. Beltramino, José de Olmos, Ferenc Gallyas, Lennart Heimer, and Lászó Záborszky

Mapping Toxicant-Induced Nervous System Damage With a Cupric Silver Stain: A Quantitative Analysis of Neural Degeneration Induced by 3,4-Methylenedioxymethamphetamine-----133
Karl F. Jensen, Jeanene Olin, Najwa Haykal-Coates, James O'Callaghan, Diane B. Miller, and José S. de Olmos

Reactions of 5-HT Neurons to Drugs of Abuse: Neurotoxicity and Plasticity-----155
Mary Ann Wilson, Laura A. Mamounas, Kenneth H. Fasman, Karen J. Axt, and Mark E. Molliver

Quantification of Reactive Gliosis as an Approach to Neurotoxicity Assessment-----188
James P. O'Callaghan and Diane B. Miller

Pharmacokinetic Approaches to the Study of Drug Action and Toxicity-----213
Arthur K. Cho, Masayuki Hiramatsu, Yoshito Kumagai, and Nita Patel

Mechanisms Mediating Biogenic Amine Deficits Induced by Amphetamine and Its Congeners-----226
James W. Gibb, Michel Johnson, Donna M. Stone, and Glen R. Hanson

Neurotoxicity and Drugs of Abuse: Cannabinoid Interaction With Brain Glucocorticoid Receptors-----242
Philip W. Landfield and J. Charles Eldridge

Nitric Oxide as a Mediator of Neurotoxicity-----253
Ted M. Dawson, Valina L. Dawson, and Solomon H. Snyder

List of NIDA Research Monographs-----274



Advanced Search | FAQs | Accessibility | Site Map | Help | NIDA Home | Privacy Policy | FOIA (NIH) | Employment | Print Version
National Institutes of Health logo Department of Health and Human Services Logo

The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH), a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Wednesday, September 18, 2002.